Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
| No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
| 1 | Alcoholism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
| 2 | Amphetamine addiction |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [1] DRD1 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
| 3 | Calcium signaling pathway |
[2] DRD1, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| 4 | cAMP signaling pathway |
[3] DRD1, DRD2, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| 5 | Cocaine addiction |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
| 6 | Dopaminergic synapse |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [5] DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
| 7 | GABAergic synapse |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
| 8 | Gap junction |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| 9 | Metabolic pathways |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 10 | Morphine addiction |
[1] DRD1 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 | ||
| 11 | Neuroactive ligand-receptor interaction |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 | ||
| 12 | Nicotine addiction |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
| 13 | Parkinson disease |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| 14 | Phenylalanine metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 15 | Rap1 signaling pathway |
[1] DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
| 16 | Retrograde endocannabinoid signaling |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
| 17 | Serotonergic synapse |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [3] GABRB1, GABRB2, GABRB3 | D04282 | Gaboxadol | [2] 201, 206 | ||
| 18 | Taste transduction |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 | D04282 | Gaboxadol | [2] 201, 206 |
| 19 | Tryptophan metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 20 | Tyrosine metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |